Dr Lang Consulting

Dr Lang Consulting GmbH provides expert consulting services for pharmaceutical R&D with a focus on the successful development, manufacture, and registration of biopharmaceutical drugs—primarily in oncology and immunology. The founder has contributed to several marketed drugs including Monjuvi®, Cyltezo®, Removab®, Pradaxa®. The firm specializes in venture development, C-level biotech management support, fundraising preparation/execution, drug development strategies from late discovery through preclinical/early clinical phases. It does not appear to directly sponsor its own clinical trials or maintain an internal therapeutic pipeline.